Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$244M |
| 2 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$143M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$137M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$109M |
| 5 |
VMW
VMware, Inc
VMW
|
+$103M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.2B |
| 2 |
Apple
AAPL
|
+$763M |
| 3 |
Microsoft
MSFT
|
+$618M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$592M |
| 5 |
AABA
Altaba Inc
AABA
|
+$393M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.41% |
| 2 | Healthcare | 5.88% |
| 3 | Financials | 5.51% |
| 4 | Consumer Discretionary | 4.79% |
| 5 | Communication Services | 4.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Equinix
EQIX
$103B
| $47.4M | 0.04% |
110,354
-20,446
| -16% | -$8.26M |
|
377
PUT
Comcast
CMCSA
$84B
| $47.4M | 0.04% |
1,443,300
-334,800
| -19% | -$10.9M |
|
378
Colgate-Palmolive
CL
$73.3B
| $47.3M | 0.04% |
730,558
-770,596
| -51% | -$50.4M |
|
379
Viatris
VTRS
$20.7B
| $47.2M | 0.04% |
1,306,266
-100,485
| -7% | -$3.94M |
|
380
S&P Global
SPGI
$122B
| $47.1M | 0.04% |
231,030
-151,710
| -40% | -$30M |
|
381
PUT
iShares Silver Trust
SLV
$28.6B
| $47M | 0.04% |
3,100,400
+259,500
| +9% | +$4.04M |
|
382
Boston Properties
BXP
$11.4B
| $46.8M | 0.04% |
373,065
-394,981
| -51% | -$47.9M |
|
383
HCA Healthcare
HCA
$85.7B
| $46.7M | 0.04% |
455,606
-125,885
| -22% | -$12.7M |
|
384
BioMarin Pharmaceuticals
BMRN
$11.7B
| $46.7M | 0.04% |
495,261
+132,231
| +36% | +$11.6M |
|
385
PUT
Procter & Gamble
PG
$335B
| $46.6M | 0.04% |
596,700
+185,200
| +45% | +$13.9M |
|
386
Eversource Energy
ES
$27.8B
| $46.4M | 0.04% |
790,810
-452,819
| -36% | -$26.1M |
|
387
PUT
Adobe
ADBE
$98.5B
| $46.3M | 0.04% |
189,900
-1,700
| -0.9% | -$402K |
|
388
CALL
Caterpillar
CAT
$373B
| $46.2M | 0.04% |
340,400
-156,600
| -32% | -$23.4M |
|
|
389
CALL
Adobe
ADBE
$98.5B
| $45.9M | 0.04% |
188,400
+49,700
| +36% | +$11.8M |
|
390
Regeneron Pharmaceuticals
REGN
$76B
| $45.9M | 0.04% |
133,077
-69,608
| -34% | -$21.8M |
|
391
PPG Industries
PPG
$24.9B
| $45.6M | 0.04% |
439,677
-165,826
| -27% | -$17.6M |
|
392
CALL
Constellation Brands
STZ
$22.3B
| $45.5M | 0.04% |
208,100
+58,900
| +39% | +$13.3M |
|
393
Synchrony
SYF
$25.1B
| $45.5M | 0.04% |
1,362,415
-602,853
| -31% | -$20.7M |
|
394
Omnicom Group
OMC
$21.8B
| $45.1M | 0.04% |
591,134
-40,129
| -6% | -$2.96M |
|
|
XYZ
395
CALL
Block Inc
XYZ
$49.2B
| $45.1M | 0.04% |
731,200
-82,900
| -10% | -$4.56M |
|
396
CALL
PepsiCo
PEP
$191B
| $45.1M | 0.04% |
413,800
+206,500
| +100% | +$21.3M |
|
397
PUT
Baidu
BIDU
$36.5B
| $45M | 0.04% |
185,100
-47,900
| -21% | -$11.9M |
|
398
CALL
United States Oil Fund
USO
$2.12B
| $44.8M | 0.04% |
371,875
-311,300
| -46% | -$34.2M |
|
399
Exelon
EXC
$46.6B
| $44.8M | 0.04% |
1,473,321
-685,315
| -32% | -$19.6M |
|
400
PUT
3M
MMM
$90.8B
| $44.7M | 0.04% |
271,851
+45,329
| +20% | +$7.74M |
|
Similar funds
Barclays's Q2 2018 Portfolio in Review
As of Q2 2018, Barclays held 7,691 positions worth $116B, down 11% from $131B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Barclays withdrew a net $18.4B in Q2 2018, closing 585 positions and reducing 3,614 holdings. Its most notable exit was Time Warner Inc, an estimated $290M position sold in full.
By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 8.6% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in Evergy worth $42M.
- Barclays's largest Q2 2018 buy was Evergy: 747,502 shares worth $42M.
- Barclays added most to State Street Industrial Select Sector SPDR ETF in Q2 2018, an estimated $244M increase.
- Barclays's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.2B.
- Barclays fully exited Time Warner Inc in Q2 2018, selling an estimated $290M.
- Barclays's ten largest holdings make up 27% of its $116B portfolio in Q2 2018.
- Barclays opened 402 new positions and closed 585 in Q2 2018.
- Barclays's portfolio value fell 11% quarter-over-quarter to $116B.
Based on Barclays's 13F filing for Q2 2018, filed 14 Aug 2018.